After patients and clinicians reported weeklong back orders of Zepbound, Eli Lilly’s new weight loss drug, the FDA confirmed shortages of two Zepbound solutions.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
FDA confirms Zepbound shortage
